Position in ABBV
as of Jun 30, 2026
· filed Jul 10, 2026
Position Value
$624,822
+$88,927 QoQ
Shares Held
2,483
+0.8% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.41%
of 13F equity value
Holder Rank
#2,974
of 4,153 holders
Holding Since
Dec 2023
11 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Walker Asset Management, LLC holds $4,561,211 across 8 Drug Manufacturers - General names. ABBV ranks #3 (13.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
671 | $804,817 | |
| 2 | JNJ |
Johnson & Johnson
|
3,132 | $795,434 | |
| 3 | ABBV |
AbbVie Inc.
This page
|
2,483 | $624,822 | |
| 4 | GILD |
Gilead Sciences, Inc.
|
4,666 | $589,502 | |
| 5 | AMGN |
Amgen Inc
|
1,411 | $510,951 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
8,616 | $496,453 | |
| 7 | MRK |
Merck & Co., Inc.
|
2,964 | $380,874 | |
| 8 | PFE |
Pfizer Inc
|
14,882 | $358,358 |
All Filings in ABBV
Export CSV
11 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $624,822 | 2,483 | Shares | Sole | 2026-07-10 | |
| 2026-03-31 | $535,895 | 2,464 | Shares | Sole | 2026-04-24 | |
| 2025-12-31 | $555,002 | 2,429 | Shares | Sole | 2026-01-16 | |
| 2025-09-30 | $558,474 | 2,412 | Shares | Sole | 2025-10-14 | |
| 2025-06-30 | $444,374 | 2,394 | Shares | Sole | 2025-07-17 | |
| 2025-03-31 | $497,190 | 2,373 | Shares | Sole | 2025-04-15 | |
| 2024-12-31 | $418,305 | 2,354 | Shares | Sole | 2025-01-15 | |
| 2024-09-30 | $460,918 | 2,334 | Shares | Sole | 2024-10-23 | |
| 2024-06-30 | $403,586 | 2,353 | Shares | Sole | 2024-07-12 | |
| 2024-03-31 | $424,657 | 2,332 | Shares | Sole | 2024-04-10 | |
| 2023-12-31 | $358,445 | 2,313 | Shares | Sole | 2024-01-08 | |
| No filing history on record for this holder in this stock. | ||||||